[{"name":"MOAB0101 - Virologic efficacy of raltegravir vs. efavirenz-based antiretroviral treatment in HIV1-infected adults with tuberculosis: W48 results of the ANRS 12300 Reflate TB2 trial \u003Csmall\u003E(ID 576)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":576,"presentation":"MOAB0101 - Virologic efficacy of raltegravir vs. efavirenz-based antiretroviral treatment in HIV1-infected adults with tuberculosis: W48 results of the ANRS 12300 Reflate TB2 trial \u003Csmall\u003E(ID 576)\u003C\/small\u003E","session":"MOAB01 - ART: Trials and tribulations \u003Csmall\u003E(ID 89)\u003C\/small\u003E","presenter":"Nathalie De Castro","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-recordings\/ias2019\/89\/v\/576_1c.mp4","source_path":"s3:\/\/us-cslide-prod-recordings\/ias2019\/89\/v\/576_1c.mp4","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-recordings\/ias2019\/89\/DDB08989.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-recordings\/ias2019\/89\/v\/576_1c.vtt","thumbnails":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-recordings\/ias2019\/89\/v\/576_1c-thumbnails.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"9E22Up0aW"}